
Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer
Keywords: مهار کننده های دارویی; Oncogenic KRAS; Pharmacological inhibitors; Pancreatic cancer; KRAS-binding ligands; RAS-effector interactions; KRAS G12C mutant-specific inhibitors; KRAS membrane anchorage; KRAS post-translational modifications; RAS-binding domain inhibitors; G-duadrupl